Correlation Between Monopar Therapeutics and Surrozen
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Surrozen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Surrozen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Surrozen, you can compare the effects of market volatilities on Monopar Therapeutics and Surrozen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Surrozen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Surrozen.
Diversification Opportunities for Monopar Therapeutics and Surrozen
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Monopar and Surrozen is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Surrozen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Surrozen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Surrozen go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Surrozen
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 4.44 times more return on investment than Surrozen. However, Monopar Therapeutics is 4.44 times more volatile than Surrozen. It trades about 0.05 of its potential returns per unit of risk. Surrozen is currently generating about 0.04 per unit of risk. If you would invest 1,310 in Monopar Therapeutics on August 29, 2024 and sell it today you would earn a total of 760.00 from holding Monopar Therapeutics or generate 58.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Monopar Therapeutics vs. Surrozen
Performance |
| Timeline |
| Monopar Therapeutics |
| Surrozen |
Monopar Therapeutics and Surrozen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Monopar Therapeutics and Surrozen
The main advantage of trading using opposite Monopar Therapeutics and Surrozen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Surrozen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will offset losses from the drop in Surrozen's long position.| Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
| Surrozen vs. Bolt Biotherapeutics | Surrozen vs. Larimar Therapeutics | Surrozen vs. Keros Therapeutics | Surrozen vs. Kezar Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |